KLK3 and posterior cortical atrophy: To further explore the safety and clinical feasibility of direct LV vaccination, and to test this approach in an appropriate pre-clinical model, we developed a self-inactivating LV to immunize against PSA—a natural Ag that is upregulated in human PCa [17].